INSIGHTS ON PHARMACEUTICAL PRODUCTION
-
Why A Leading Manufacturing Partner Chose NeoTOP Packaging Machines
Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.
-
Insights And Strategies For GMP Manufacturing Of RNA-Lipid Nanoparticles
The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?
-
Production And Purification Of AAV At The 50 L Scale
Explore data demonstrating the performance of a scalable system for AAV manufacturing that enables gene therapy researchers to utilize a single system throughout the entire development process.
-
Expansion Of Specific Lymphocytes With A Xeno-Free, Serum-Free Medium
Explore the advantages of utilizing a xeno- and serum-free medium for the targeted expansion of cell subpopulations without the addition of serum.
-
Oligonucleotide Synthesis: Scale-Up Made Simple10/16/2024
Scaling oligonucleotide synthesis isn't as straightforward as it seems. Explore key challenges, critical process parameters, and solutions for a smooth scale-up.
-
Intensifying Downstream Bioprocessing With Continuous Technologies9/9/2024
Watch to explore intensified downstream bioprocessing in-depth and take the first step toward a more innovative and efficient future in bioprocessing.
-
Expediting Lentiviral Vector Development With Automated Bioreactors And Design Of Experiments4/4/2025
Discover how Seattle Children's Therapeutics leveraged tools to develop an efficient in-house lentiviral vector production process to accelerate timelines and enhance productivity through precise, data-driven estimations.
-
Migrating Peptide Mapping Methods With Innovative Technology9/12/2024
See how you can achieve seamless method transfer from systems equipped with quaternary or binary solvent managers, maintaining separation selectivity without time-consuming method re-optimization.
-
Future ATMP Manufacturing Paradigms, Part 23/28/2025
Discover how AI, Industry 4.0, and innovative drug containers are transforming the future of Advanced Therapy Medicinal Product (ATMP) manufacturing for better patient outcomes.
PHARMACEUTICAL PRODUCTION SOLUTIONS
-
OligoProcess covers a range of 10 to 1800 mmol and is suitable for quantities required in clinical phases and commercial production.
-
We are the exclusive manufacturing partner for this innovative auto-injector platform.
-
Used 125 liter Lee Tri Mix Turbo Shear triple shaft reactor, 316 stainless steel construction, model 125LD12T, 15 Ra electropolished internal finish, approximately 25" diameter x 5" straight side, hinged dish top, hemispherical bottom, rated 50 psi and full vacuum at 300 f internal, jacketed for 150 psi at 366 f, top entering double motion agitator with sidewall scrappers and inner opposing paddles driven by 5 hp motor drive, center top entering mixer emulsifier with direct coupled 7.5 hp motor, agitator system bridge mounted with hinged tilt, water actuated tilting cylinder, mounted on stainless steel unitized base with control panel with motor vfd controllers, serial# 81004-1, national board# 12861, built 2014.
-
Used Diosna P1/6 High Shear Granulator. S/N: 355-152
-
Explore scalable and flexible single-use solutions from design to delivery that can help you overcome challenges throughout adeno-associated virus (AAV) manufacturing workflow.